Latest Kenvue News & Updates

See the latest news and media coverage for Kenvue. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Kenvue

Global consumer health company

kenvue.com
Headquarters
Summit, United States
Founded year
2023
Company type
Public company
Number of employees
15,000+

Last updated

Latest news about Kenvue

In short: Kenvue shareholders approved a $48.7 billion merger with Kimberly-Clark as the company managed complex Tylenol-related litigation and job cuts.

Company announcements

  • Kenvue

    Kenvue reports Q1 2026 results

    Net sales rose 4.5% with organic growth of 0.7%. Diluted EPS increased to $0.25. Pending merger with Kimberly-Clark awaits approvals.

  • Kenvue

    Kenvue announces future Enterprise Leadership Team

    The announcement provides clarity and momentum for the Kenvue-Kimberly-Clark combination, closing in late 2026. It builds a global health and wellness leader.

  • Kenvue

    Kenvue announces Aveeno Mayo Clinic collaboration

    The three-year partnership advances skin health science through research, education, and Triple Oat focus for compromised skin.

  • Kenvue

    Kenvue announces Zyrtec PGA TOUR partnership

    Zyrtec becomes the league's first Official Allergy Relief Sponsor in a multiyear deal alongside the Yes Season™ campaign.

Unlock all announcements with a

Media coverage

  • MarketWatch

    Kenvue 1Q Profit, Sales Climb as Turnaround Efforts Take Hold

    Kenvue reported higher profit and sales in the first quarter as it implements a strategy to turn around its business ahead of its acquisition by...

  • Yahoo Finance

    Kenvue Declares Quarterly Cash Dividend

    Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly...

  • MSN

    Kimberly-Clark to buy Tylenol maker Kenvue for $48.7 billion

    (Reuters) — Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, to create one of...

  • MSN

    Billionaire investor cuts Tylenol maker Kenvue stake by 64%

    Hedge fund billionaire Daniel Loeb slashed his stake in the consumer health company Kenvue Inc. KVUE at Third Point LLC in the fourth quarter of...

Unlock all articles with a

Never miss news about Kenvue

Track Kenvue and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.